Skip to main content
OpenTrials

Clinical trial condition

Human Epidermal Growth Factor Receptor 2 Negative (HER2-Negative) Breast Cancer

Explore clinical trials studying Human Epidermal Growth Factor Receptor 2 Negative (HER2-Negative) Breast Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Human Epidermal Growth Factor Receptor 2 Negative (HER2-Negative) Breast Cancer trial results

Completed

A Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain Metastasis

NCT01173497

Conditions
Brain Diseases, Brain Metastases, Brain Neoplasms, +14 more
Locations
  • University of Alabama At Birmingham Birmingham, Alabama, United States
  • University of California At San Francisco San Francisco, California, United States
  • Georgetown University Washington D.C., District of Columbia, United States
  • University of Chicago Chicago, Illinois, United States
View all 13 locations
View Trial Details

Related conditions